Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid in laparoscopic stripping of ovarian endometrioma
IRCT20240908062973N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid in endometrioma (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Ovarian reserve and Operation time. Started Nov 2024; status: completed.
02
Drugs
tranexamic acid
03
Conditions
endometrioma
Beyond the preview
Go deeper on IRCT20240908062973N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240908062973N2.